Literature DB >> 25451233

CXCL14 is no direct modulator of CXCR4.

Maik Otte1, Andrea Kliewer1, Dagmar Schütz1, Christiane Reimann1, Stefan Schulz1, Ralf Stumm2.   

Abstract

C-X-C motif chemokine 12/C-X-C chemokine receptor type 4 (CXCL12/CXCR4) signaling is involved in ontogenesis, hematopoiesis, immune function and cancer. Recently, the orphan chemokine CXCL14 was reported to inhibit CXCL12-induced chemotaxis - probably by allosteric modulation of CXCR4. We thus examined the effects of CXCL14 on CXCR4 regulation and function using CXCR4-transfected human embryonic kidney (HEK293) cells and Jurkat T cells. CXCL14 did not affect dose-response profiles of CXCL12-induced CXCR4 phosphorylation, G protein-mediated calcium mobilization, dynamic mass redistribution, kinetics of extracellular signal-regulated kinase 1 (ERK1) and ERK2 phosphorylation or CXCR4 internalization. Hence, essential CXCL12-operated functions of CXCR4 are insensitive to CXCL14, suggesting that interactions of CXCL12 and CXCL14 pathways depend on a yet to be identified CXCL14 receptor.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AMD3100; AMD3465; CXCL12; CXCL14; CXCR4; CXCR4 antagonist; Dynamic mass redistribution

Mesh:

Substances:

Year:  2014        PMID: 25451233     DOI: 10.1016/j.febslet.2014.11.009

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Identification of Phosphorylation Sites Regulating sst3 Somatostatin Receptor Trafficking.

Authors:  Andreas Lehmann; Andrea Kliewer; Thomas Günther; Falko Nagel; Stefan Schulz
Journal:  Mol Endocrinol       Date:  2016-04-21

Review 2.  Mucosal Chemokines.

Authors:  Marcela Hernández-Ruiz; Albert Zlotnik
Journal:  J Interferon Cytokine Res       Date:  2017-02       Impact factor: 2.607

Review 3.  The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses.

Authors:  Joseph A Westrich; Daniel W Vermeer; Paul L Colbert; William C Spanos; Dohun Pyeon
Journal:  Mol Carcinog       Date:  2020-03-24       Impact factor: 4.784

4.  Cxcl14 depletion accelerates skeletal myogenesis by promoting cell cycle withdrawal.

Authors:  Rachel J Waldemer-Streyer; Adriana Reyes-Ordoñez; Dongwook Kim; Rongping Zhang; Nilmani Singh; Jie Chen
Journal:  NPJ Regen Med       Date:  2017-01-05

5.  Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.

Authors:  Paul J Collins; Michelle L McCully; Laura Martínez-Muñoz; César Santiago; James Wheeldon; Stephan Caucheteux; Sylvia Thelen; Valentina Cecchinato; Julia M Laufer; Vladimir Purvanov; Yoan R Monneau; Hugues Lortat-Jacob; Daniel F Legler; Mariagrazia Uguccioni; Marcus Thelen; Vincent Piguet; Mario Mellado; Bernhard Moser
Journal:  FASEB J       Date:  2017-03-30       Impact factor: 5.191

6.  CXCL14 Maintains hESC Self-Renewal through Binding to IGF-1R and Activation of the IGF-1R Pathway.

Authors:  Chih-Lun Cheng; Shang-Chih Yang; Chien-Ying Lai; Cheng-Kai Wang; Ching-Fang Chang; Chun-Yu Lin; Wei-Ju Chen; Po-Yu Lin; Han-Chung Wu; Nianhan Ma; Frank Leigh Lu; Jean Lu
Journal:  Cells       Date:  2020-07-16       Impact factor: 6.600

Review 7.  The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.

Authors:  Jan Korbecki; Klaudyna Kojder; Patrycja Kapczuk; Patrycja Kupnicka; Barbara Gawrońska-Szklarz; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

8.  Cluster analysis of splenocyte microRNAs in the pig reveals key signal regulators of immunomodulation in the host during acute and chronic Toxoplasma gondii infection.

Authors:  Zhaofeng Hou; Hui Zhang; Kangzhi Xu; Shifan Zhu; Lele Wang; Dingzeyang Su; Jiantao Liu; Shijie Su; Dandan Liu; Siyang Huang; Jinjun Xu; Zhiming Pan; Jianping Tao
Journal:  Parasit Vectors       Date:  2022-02-17       Impact factor: 3.876

9.  A strategy to discover decoy chemokine ligands with an anti-inflammatory activity.

Authors:  Dayana Abboud; François Daubeuf; Quoc Tuan Do; Valérie Utard; Pascal Villa; Jacques Haiech; Dominique Bonnet; Marcel Hibert; Philippe Bernard; Jean-Luc Galzi; Nelly Frossard
Journal:  Sci Rep       Date:  2015-10-07       Impact factor: 4.379

Review 10.  CXCL14 as an emerging immune and inflammatory modulator.

Authors:  Jing Lu; Mita Chatterjee; Hannes Schmid; Sandra Beck; Meinrad Gawaz
Journal:  J Inflamm (Lond)       Date:  2016-01-05       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.